Idiopathic myelofibrosis (agnogenic myeloid metaplasia): Clinicopathological analysis of 32 patients

Leukemia Research

Volumn 21, Issue 2, 1997, Pages 125-131

  Özen, Süleyman ^a   Ferhanoǧlu, Burhan ^b   Şenocak, Mustafa ^a   Tüzüner, Nükhet ^a,b  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Idiopathic myelofibrosis; Prognosis

Indexed keywords

COLLAGEN; RETICULIN;

ADULT; AGE; AGED; ANEMIA; ARTICLE; BONE MARROW; BONE MARROW BIOPSY; CELL HYPERPLASIA; CLINICAL CHEMISTRY; ERYTHROID CELL; FEMALE; HEMATOCRIT; HEMATOPOIESIS; HUMAN; HUMAN CELL; LEUKOCYTE COUNT; LIVER SIZE; MALE; MEGAKARYOCYTE; MYELOFIBROSIS; PRIORITY JOURNAL; PROGNOSIS; RETICULOCYTE; SPLEEN SIZE; SURVIVAL TIME; THROMBOCYTE COUNT;

EID: 0031079753     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(96)00095-1     Document Type: Article

References (30)

1. 1. Dameshek W. (1951) Some speculations on the myeloproliferative syndrome. Blood 6, 372.
2. 2. Varki A., Lotterborg R., Griffith R. & Reinhard E. (1983) The syndrome of idiopathic myelofibrosis. A clinicopathologic review with emphasis of the prognostic variables predicting survival. Medicine 62, 353.
3. 3. Visani G., Finelli C., Castelli U., Petti M., Ricci P., Vianelli N., Gianni L., Zuffa E., Alve Spiriti M. A., Latagliata R., Pileri S., Magrini U., Gugliotta L., Morra E., Bernasconi C., Mandelli F. & Tura S. (1990) Myelofibrosis with myeloid metaplasia: Clinical and hematological parameters predicting survival in a series of 133 patients. Br. J. Haematol. 75, 4.
4. 4. Weinstein I. M. (1991) Idiopathic myelofibrosis: Historical review, diagnosis and management. Blood Rev. 5, 98.
5. 5. Hasselbalch H. (1990) Idiopathic myelofibrosis: A clinical study of 80. Am. J. Hematol. 34, 291.
6. 6. Hasselbalch H. & Jensen B. A. (1990) Prognostic factors in idiopathic myelofibrosis: A simple scoring system with prognostic significance. Eur. J. Haematol. 44, 172.
7. 7. Wolf B. C. & Neiman R. S. (1985) Myelofibrosis with myeloid metaplasia: Pathophysiologic implications of the correlations between bone marrow changes and progression of splenomegaly. Blood 65, 4, 803.
8. 8. Van Slyck E. J., Weiss L. & Dully M. (1970) Chromosomal evidence for the secondary role of fibroblastic proliferation in acute myelofibrosis. Blood 36, 6, 729.
9. 9. Reilly J. T. (1992) Pathogenesis of idiopathic myelofibrosis: Role of growth factors. J. Clin. Pathol. 45, 461.
10. 10. Kreipe H., Jaquet K., Feigner J., Radzun H. J. & Parwaresch R. (1991) Clonal granulocytes and bone marrow cells in the cellular phase of agnogenic myeloid metaplasia. Blood 78, 7, 1814.
11. 11. Reilly J. T., Barnett D., Dolan G., Forrest P., Eastham J. & Smith A. (1993) Characterization of an acute micromegakaryocytic leukemia. Evidence for the pathogenesis of myelofibrosis. Br. J. Haematol. 83, 58.
12. 12. Reilly J. T. (1994) Pathogenesis of idiopathic myelofibrosis: Present status and future directions. Br. J. Haematol. 88, 1.
13. 13. Gustavsson P., Holm J., Wahlin A. & Norberg B. (1985) Staging of idiopathic myelofibrosis: Significance of hemoglobin value and reticulocyte count. Acta Med. Scan. 218, 487.
14. 14. Takaesi-Naqy L. & Graf F. (1975) Definition, clinical features and diagnosis of myelofibrosis. Clin. Haematol. 4, 373.
15. 15. Barosi G., Berzuini C., Liberato L. N., Costo A., Polino G. & Ascari E. (1988) A prognostic classification of myelofibrosis with myeloid metaplasia. Br. J. Haematol. 70, 397.
16. 16. Kaplan E. I. & Meier P. (1958) Nonparametric estimation from incomplete observation. J. Am. Stat. 53, 457.
17. 17. Mantel N. (1966) Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemo. Res. 50, 163.
18. 18. Breslow N. (1970) A generalized Kruskal-Wallis test for comparing K samples subject to unequal patterns of censorship. Biometrika 57, 579.
19. 19. Njoku O. S., Lewis S. M., Catovsky D. & Gordon-Smith E. C. (1983) Anemia in myelofibrosis: its value in prognosis. Br. J. Haematol. 54, 79.
20. 20. Borosi G., Baraldi A., Cazzola M., Spriano P. & Magrini U. (1983) Red cell aplasia in myelofibrosis with myeloid metaplasia. A distinct functional and clinical entity. Cancer 51, 1290.
21. 21. Pereira A., Cervantes F., Brugues R. & Rozman C. (1990) Bone marrow histopathology in primary myelofibrosis: Clinical and hematological correlations and prognostic evaluation. Eur. J. Haematol. 44, 94.
22. 22. Hasselbalch H. & Lisse I. (1991) A sequential histological study of bone marrow fibrosis in idiopathic myelofibrosis. Eur. J. Haematol 46, 285.
23. 23. Hasselbalch H. (1993) Idiopathic myelofibrosis. Clinical aspects and studies on extracellular metabolism matrix. Dan. Med. Bull. 40, 39.
24. 24. Lohman T. P. & Beckman E. N. (1983) Progressive myelofibrosis in agnogenic myeloid metaplasia. Arch. Pathol. Lab. Med. 107, 593.
25. 25. Thile J., Klein H., Falk S., Bersch H. P., Fischer R. & Stutte H. J. (1992) Splenic megakaryopoiesis in primary osteomyelofibrosis. An immuno-histological and morphometric study with comparison of corresponding bone marrow features. Acta Haematol. 87, 176.
26. 26. Thiele J., Wagner S., Bersch H. P., Wienhold S. & Fischer R. (1990) Pro-megakaryoblast in bone marrow tissue from patients with primary osteo-myelofibrosis (agnogenic myeloid metaplasia). Path. Res. Pract. 186, 589.
27. 27. Ohsaka A., Miura Y., Takahashi A. & Yokoyama T. (1991) Morphometric analysis of myelofibrosis in agnogenic myeloid metaplasia and chronic myelogenous leukemia. Virchows Arch-B-Cell Pathol. 60, 6, 399.
28. 28. Rupoli S., Da Lio L., Sisti S., Campanati G., Salvi A., Brianzoni M. F., D'Amico S., Cicciripini A. & Leoni P. (1994) Primary myelofibrosis: A detailed statistical analysis of the clinicopathologic variables influencing survival. Ann. Hematol. 68, 205.
29. 29. Bentley S. A., Alabaster O. & Foidart J. M. (1977) Erythroid hypoplasia in myelofibrosis: a feature associated with blastic transformation. Br. J. Haematol. 36, 41.
30. 30. Rozman C., Giralt M., Feliu E., Rubio D. & Cortes M. T. (1991) Life expectancy of patients with chronic non leukemic myeloproliferative disorders. Cancer 67, 2658.